InvestorsHub Logo
Followers 1
Posts 59
Boards Moderated 0
Alias Born 08/19/2021

Re: Blue Skys post# 2071

Monday, 10/04/2021 5:25:42 AM

Monday, October 04, 2021 5:25:42 AM

Post# of 5331
I agree with that benefit (avoid the jab) but I think that’s what is slowing down any official green lights around antibody testing from the FDA or the CDC. I believe that there is some real level of uncertainty around antibodies and titers and what it says about our immunity level (but just as much uncertainty as there is around everything else Covid related). I think they fear that antibody tests if acknowledged as conclusive in determining immunity will further emboldened those already unsure about the vaccine and make it even more difficult to get the whole country vaccinated and enforce mandates. (I’m addition they fear mask mandates will be tossed aside as well) Then from that “semi-well intentioned” stepping stone it’s a light lift for connected big Pharma who are committed now to needing Vax profits to use their influence to suppress
antibody testing and limit its official acceptance. I do not agree with this approach. It feels like a “the people can’t handle the truth so we will tell them half of the truth for their own good” kind of sheep mentality.
I frequently see articles that reference NABs detection and titer levels as the accepted method to determine “vaccine effectiveness”. Vaccine effectiveness = immunity. Completely contradicting what is said in articles strictly about antibody testing Hello!!!?!?!? It does not add up
My feeling is that soon this will unavoidably change as more people are vaccinated and antibody testing organically hits that sweet. The perfect compromise between governments and those that will never take the jab no matter what. I think it will start in Europe (UK taking the lead) and make its way here.

For the record , I am vaccinated but I stand with those who do not want to be forced to be vaccinated. Let them have Immunopass!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News